Strentococcus bovis revisited: A clinical review of 81 bacteremic episodes paying special attention to emerging antibiotic resistance

被引:8
作者
Siegman-Igra, Y
Schwartz, D
机构
[1] Tel Aviv Sourasky Med Ctr, Infect Dis Unit, IL-64239 Tel Aviv, Israel
[2] Tel Aviv Sourasky Med Ctr, Microbiol Lab, IL-64239 Tel Aviv, Israel
[3] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
关键词
D O I
10.1080/0036554021000027007
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Following 2 cases of Streptococcus bovis endocarditis with a high level of resistance to clindamycin during 2002, the authors reviewed their clinical experience with S. bovis bacteremia during 2 periods, starting in 1980. 81 episodes of S. bovis bacteremia represented approximately 1% of all episodes of bacteremia. In 32 (40%) cases the bacteremia represented endocarditis, in 15 (19%) the bacteremia originated from sick bowel, 11 (14%) were suspected to arise from urinary tract infection, 10 (12%) originated from biliary or peritoneal infection, and 13 from other or unknown sources. 25 (31%) of the bacteremias were polymicrobial. All of the isolates were highly susceptible to penicillin and clindamycin, with the following exceptions: 2 isolates had a minimal inhibitory concentration (MIC) of 0.5 mg/l to penicillin (in 1997) and 5 isolates had an MIC of > 2 mg/l to clindamycin (in 1997, 1998, 2000 and 2002). The 2 most recent of these 5 had high-level resistance to clindamycin of > 256 mg/l. It seems that clindamycin resistance in S. bovis is an emerging phenomenon, in contrast to penicillin resistance, high levels of which have not yet been described in S. bovis.
引用
收藏
页码:90 / 93
页数:4
相关论文
共 32 条
[1]  
Ballet M, 1995, EUR HEART J, V16, P1975
[2]  
Carfagna Paolo, 1998, Recenti Progressi in Medicina, V89, P552
[3]   Streptococcus bovis infection of the central nervous system: Report of two cases and review [J].
Cohen, LF ;
Dunbar, SA ;
Sirbasku, DM ;
Clarridge, JE .
CLINICAL INFECTIOUS DISEASES, 1997, 25 (04) :819-823
[4]   Definite Streptococcus bovis endocarditis:: characteristics in 20 patients [J].
Duval, X ;
Papastamopoulos, V ;
Longuet, P ;
Benoit, C ;
Perronne, C ;
Leport, C ;
Vildé, JL .
CLINICAL MICROBIOLOGY AND INFECTION, 2001, 7 (01) :3-10
[5]   INFECTIVE ENDOCARDITIS DUE TO PENICILLIN-TOLERANT STREPTOCOCCUS-BOVIS [J].
FUNG, JC ;
GADBAW, JJ ;
DONTA, ST ;
TILTON, RC .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1986, 5 (02) :171-176
[6]   Prevalence of liver disease in patients with Streptococcus bovis bacteraemia [J].
González-Quintela, A ;
Martínez-Rey, C ;
Castroagudín, JF ;
Rajo-Iglesias, MC ;
Domínguez-Santalla, MJ .
JOURNAL OF INFECTION, 2001, 42 (02) :116-119
[7]   STREPTOCOCCUS-BOVIS SEPTICEMIA AND PANCREATIC ADENOCARCINOMA [J].
HERRINGTON, P ;
FINKELMAN, D ;
BALART, L ;
HINES, C ;
FERRANTE, W .
ANNALS OF INTERNAL MEDICINE, 1980, 92 (03) :441-441
[8]   NONENTEROCOCCAL GROUP-D STREPTOCOCCAL ENDOCARDITIS CAUSED BY STREPTOCOCCUS-BOVIS [J].
HOPPES, WL ;
LERNER, PI .
ANNALS OF INTERNAL MEDICINE, 1974, 81 (05) :588-593
[9]   In vitro activity of gemifloxacin (SB-265805) compared to eleven other antimicrobial agents against streptococcal isolates, excluding Streptococcus pneumoniae [J].
Kerawala M. ;
Ambler J.E. ;
Lee P.Y.C. ;
Drabu Y.J. .
European Journal of Clinical Microbiology and Infectious Diseases, 2001, 20 (4) :271-275
[10]   STREPTOCOCCUS-BOVIS SEPTICEMIA AND CARCINOMA OF THE COLON [J].
KLEIN, RS ;
CATALANO, MT ;
EDBERG, SC ;
CASEY, JI ;
STEIGBIGEL, NH .
ANNALS OF INTERNAL MEDICINE, 1979, 91 (04) :560-562